المؤلفون: Johnson, M. B., Ogishi, M., Domingo-Vila, C., De Franco, E., Wakeling, M. N., Imane, Z., Resnick, B., Williams, E., Galão, R. P., Caswell, R., Russ-Silsby, J., Seeleuthner, Y., Rinchai, D., Fagniez, I., Benson, B., Dufort, M. J., Speake, C., Smithmyer, M. E., Hudson, M., Dobbs, R., Quandt, Z., Hattersley, A. T., Zhang, P., Boisson-Dupuis, S., Anderson, M. S., Casanova, J. L., Tree, T. I., Oram, R. A.

مصطلحات موضوعية: Child, Preschool, Humans, Infant, Newborn, Autoimmunity, B7-H1 Antigen/deficiency/genetics/immunology, Diabetes Mellitus, Type 1/genetics/immunology, Homozygote, Programmed Cell Death 1 Receptor/deficiency/genetics/immunology

Relation: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/38634869/; Johnson MB, Ogishi M, Domingo-Vila C, De Franco E, Wakeling MN, Imane Z, et al. Human inherited PD-L1 deficiency is clinically and immunologically less severe than PD-1 deficiency. The Journal of experimental medicine. 2024;221(6).; The Journal of experimental medicine; PMC11032109 GentiBio outside the submitted work. M.S. Anderson reported other from Merck, Inc. outside the submitted work. R.A. Oram reported grants from Randox, and personal fees from Sanofi, Provention Bio, and Janssen outside the submitted work; and that Randox are licensing knowhow relating to T1D polygenic scores from the University of Exeter. No other disclosures were reported.; https://hdl.handle.net/11287/623330

الاتاحة: https://hdl.handle.net/11287/623330
https://doi.org/10.1084/jem.20231704